A novel drug delivery system has been developed by scientists from the USA, Canada and France which can cross the blood-brain barrier to reach the cancer cells in the brain and kill them. Currently, the technology is in Phase I of its clinical trial. At present, not even 5 % of drugs can cross this barrier. The non-invasive tool is being developed by Angiochem Inc.